Literature DB >> 22000877

Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris.

Emma E Craythorne, Ghulam Mufti, Anthony W DuVivier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22000877     DOI： 10.1016/j.jaad.2010.06.033

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

1.  Rituximab in Pemphigus: Road Covered and Challenges Ahead.

Authors:  Keshavamurthy Vinay; Sunil Dogra
Journal:  Indian Dermatol Online J       Date:  2018 Nov-Dec

2.  Rituximab in the treatment of pemphigus vulgaris.

Authors:  Labib R Zakka; Shawn S Shetty; A Razzaque Ahmed
Journal:  Dermatol Ther (Heidelb)       Date:  2012-11-15

3.  A Comparative Study to Evaluate the Efficacy and Cost of Rituximab versus Dexamethasone Cyclophosphamide Pulse in Patients of Pemphigus Vulgaris.

Authors:  Sudip Das; Komal Agarwal; Sonal Singh; Deepika Halder; Sujata Sinha; Abhishek De
Journal:  Indian J Dermatol       Date:  2021 Mar-Apr       Impact factor: 1.494
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.